Skip to main content
Equibles

KRSNAA · Krsnaa Diagnostics Limited

Use KRSNAA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KRSNAA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
528.75 INR +10.70 (+2.07%) At close · Nov 13
Rebalance outlook locked
Market Cap
17.15B INR
Shares
32.44M
Volume · Nov 13 197.4K Avg daily vol (3M) 124.77K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close528.75 INR Open514.35 INR Day509.55–540.50 INR 52W close475.00–826.80 INR Avg vol 30d74K Last earningsNov 3, 2026 DataAug 2021–Nov 2026

Latest documents

2026
Nov 3
Earnings call
Record Q2 revenue rises as margins ease

Krishna Diagnostics Limited reported record Q2 FY27 operating revenue of Rs. 271 crore, up 32%, while H1 FY27 revenue reached 507 crore, up approximately 27%; EBITDA margin declined to 27% from 29%.

4 source passages
On behalf of Krishna Diagnostics Limited, that concludes this conference. Starting with our consolidated Q2FY27 performance, Revenue from operations stood at Rs. 271 crore, compared with Rs. 206 crore in Q2 FY26, registering a year-on-year growth of 32%. EBITDA margin stood at 27%, compared with 29% in Q2 FY26. Now coming to H1FY27, revenue from operations stood at 507 crore compared with 399 crore in H1FY26, deflecting a growth of approximately 27%. Open the document at this passage
All documents

Quarterly results

Revenue Net income Net loss
▲10.2% 1.75B INR 194.15M INR '25 Q3 ▲11.9% 1.86B INR 206.78M INR '25 Q4 ▲13.4% 1.93B INR 205.20M INR '26 Q1 ▲10.5% 2.06B INR 239.45M INR '26 Q2 ▲3.8% 1.81B INR 0 INR '26 Q3 ▲3.5% 1.93B INR 417.18M INR '26 Q4 ▲22.1% 2.36B INR 165.51M INR '27 Q1 LATEST ▲31.5% 2.71B INR 245.87M INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 475.00 INR Now 528.75 INR · 15% Range high 826.80 INR
vs 200-day avg -8% vs 50-day avg 0%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XNSE:KRSNAA +11.3% -0.9% -6.0% +5.0% -26.7%

Exchange listing

Market
XNSE
Ticker
KRSNAA
ISIN
INE08LI01020
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.krsnaadiagnostics.com/
Investor relations
https://krsnaadiagnostics.com/investors/

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

Ex-dividend dateAmount per share
2026-09-18 2.00 INR
2025-09-12 2.75 INR
2024-09-13 2.50 INR
2023-09-15 2.75 INR
2022-09-15 2.50 INR

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-11-03 Audio Transcript
    Earnings Call for the Quarter Ended September 30, 2026
  • Earnings call · Q1 2027 2026-08-14 Transcript
    Earnings Call for the Quarter Ended June 30, 2026
  • Earnings call · Q4 2026 2026-05-26 Transcript
    Earnings Call for the Quarter Ended March 31, 2026